Open access
Sep 2026
Discovery of Selective Small-Molecule Ligands of SV2C by AI-Enhanced Virtual Screening and Experimental Validation
An AI-enhanced virtual screening pipeline delivered selective SV2C ligands from a general chemical library, providing tools to probe SV2C biology in Parkinson’s disease.
Alexander C. Brueckner, Matthew F. Martin, Sheenam Khuttan et al.
· bioRxiv · 0 citations